Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Nov;13(11):661-673.
doi: 10.1038/nrendo.2017.97. Epub 2017 Sep 1.

Genomic and epigenomic mechanisms of glucocorticoids in the brain

Affiliations
Review

Genomic and epigenomic mechanisms of glucocorticoids in the brain

Jason D Gray et al. Nat Rev Endocrinol. 2017 Nov.

Abstract

Following the discovery of glucocorticoid receptors in the hippocampus and other brain regions, research has focused on understanding the effects of glucocorticoids in the brain and their role in regulating emotion and cognition. Glucocorticoids are essential for adaptation to stressors (allostasis) and in maladaptation resulting from allostatic load and overload. Allostatic overload, which can occur during chronic stress, can reshape the hypothalamic-pituitary-adrenal axis through epigenetic modification of genes in the hippocampus, hypothalamus and other stress-responsive brain regions. Glucocorticoids exert their effects on the brain through genomic mechanisms that involve both glucocorticoid receptors and mineralocorticoid receptors directly binding to DNA, as well as by non-genomic mechanisms. Furthermore, glucocorticoids synergize both genomically and non-genomically with neurotransmitters, neurotrophic factors, sex hormones and other stress mediators to shape an organism's present and future responses to a stressful environment. Here, we discuss the mechanisms of glucocorticoid action in the brain and review how glucocorticoids interact with stress mediators in the context of allostasis, allostatic load and stress-induced neuroplasticity.

PubMed Disclaimer

References

    1. Endocrinology. 2005 Mar;146(3):1438-48 - PubMed
    1. Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4862-7 - PubMed
    1. Biol Psychiatry. 2006 Jun 15;59(12):1116-27 - PubMed
    1. Proc Natl Acad Sci U S A. 2012 Jul 17;109(29):11776-81 - PubMed
    1. Proc Natl Acad Sci U S A. 2015 Jun 2;112(22):6828-33 - PubMed

MeSH terms

Substances